Your browser doesn't support javascript.
loading
Somatic mutation as a mechanism of Wnt/ß-catenin pathway activation in CLL.
Wang, Lili; Shalek, Alex K; Lawrence, Mike; Ding, Ruihua; Gaublomme, Jellert T; Pochet, Nathalie; Stojanov, Petar; Sougnez, Carrie; Shukla, Sachet A; Stevenson, Kristen E; Zhang, Wandi; Wong, Jessica; Sievers, Quinlan L; MacDonald, Bryan T; Vartanov, Alexander R; Goldstein, Natalie R; Neuberg, Donna; He, Xi; Lander, Eric; Hacohen, Nir; Regev, Aviv; Getz, Gad; Brown, Jennifer R; Park, Hongkun; Wu, Catherine J.
Afiliación
  • Wang L; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Shalek AK; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;
  • Lawrence M; Broad Institute, Cambridge, MA;
  • Ding R; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;
  • Gaublomme JT; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;
  • Pochet N; Broad Institute, Cambridge, MA;
  • Stojanov P; Broad Institute, Cambridge, MA;
  • Sougnez C; Broad Institute, Cambridge, MA;
  • Shukla SA; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Stevenson KE; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;
  • Zhang W; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Wong J; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Sievers QL; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • MacDonald BT; F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA; Department of Neurology, Harvard Medical School, Boston, MA;
  • Vartanov AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Goldstein NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Neuberg D; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;
  • He X; F. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA; Department of Neurology, Harvard Medical School, Boston, MA;
  • Lander E; Broad Institute, Cambridge, MA;
  • Hacohen N; Broad Institute, Cambridge, MA; Division of Allergy, Immunology and Rheumatology, Department of Medicine, Massachusetts General Hospital, Boston MA; and.
  • Regev A; Broad Institute, Cambridge, MA;
  • Getz G; Broad Institute, Cambridge, MA;
  • Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Park H; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA;
  • Wu CJ; Cancer Vaccine Center, and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Blood ; 124(7): 1089-98, 2014 Aug 14.
Article en En | MEDLINE | ID: mdl-24778153
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Transducción de Señal / Beta Catenina / Vía de Señalización Wnt / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Transducción de Señal / Beta Catenina / Vía de Señalización Wnt / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article